← FDA DRUG APPROVALS

FDA NDA · NDA019452

DERMOTIC

fluocinolone acetonide

Sponsor: HILL DERMAC

APPLICATION
NDA019452
TYPE
NDA
ORIGINAL APPROVAL
1988-02-03
LATEST ACTION
2024-08-30
ROUTE
AURICULAR (OTIC), TOPICAL, OTIC
DOSAGE FORM
OIL, OIL/DROPS
MARKETING STATUS
Prescription

Products

DERMA-SMOOTHE/FS · ReferencePrescription
FLUOCINOLONE ACETONIDE 0.01% · OIL · TOPICAL
DERMA-SMOOTHE/FS · ReferencePrescription
FLUOCINOLONE ACETONIDE 0.01% · OIL · TOPICAL
DERMOTIC · ReferencePrescription
FLUOCINOLONE ACETONIDE 0.01% · OIL/DROPS · OTIC

Approval history

2024-08-30Labeling · Supplement 27 · standardLabelAP
2020-01-29Labeling · Supplement 40 · standardLetterAP
2016-12-13Manufacturing (CMC) · Supplement 28 · standardAP
2007-12-12Efficacy · Supplement 24 · unknownLabelAP
2007-12-03Manufacturing (CMC) · Supplement 25AP
2005-11-09Labeling · Supplement 16 · standardLabelAP
2005-11-09Efficacy · Supplement 20 · standardLetterAP
2005-11-09Efficacy · Supplement 19 · standardLetterAP
2003-04-21Manufacturing (CMC) · Supplement 18 · standardLabelAP
2001-10-10Efficacy · Supplement 17 · standardLetterAP
1999-08-18Efficacy · Supplement 15 · standardLetterAP
1997-02-04Manufacturing (CMC) · Supplement 14 · standardAP
1996-08-27Manufacturing (CMC) · Supplement 7 · standardAP
1996-04-26Manufacturing (CMC) · Supplement 13 · standardAP
1996-01-30Manufacturing (CMC) · Supplement 12 · standardAP
1995-02-16Efficacy · Supplement 10 · standardAP
1995-02-16Labeling · Supplement 9 · standardAP
1992-06-25Manufacturing (CMC) · Supplement 8 · standardAP
1990-10-16Manufacturing (CMC) · Supplement 5 · standardAP
1990-01-10Manufacturing (CMC) · Supplement 4 · standardAP
1989-06-27Manufacturing (CMC) · Supplement 3 · standardAP
1989-03-15Manufacturing (CMC) · Supplement 2 · standardAP
1988-09-08Manufacturing (CMC) · Supplement 1 · standardAP
1988-02-03Type 3 - New Dosage Form · Original · standardPediatric Medical ReviewAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →